The US Varicose Vein Treatment Devices Market For 2006 Is Portrayed Inside Up-To-Date Research.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c44590) has announced the addition of US Markets for Varicose Vein Treatment Devices 2006 to their offering. In 2005, the US market for varicose vein treatment devices was valued at nearly $100 million and is expected to grow over 10% by 2010. This market consists of greater saphenous vein (GSV GSV Greater Saphenous Vein GSV Genealogical Society of Victoria (Australia) GSV Garnisonen I Sør-Varanger (Norway military Garrison of Sør-Varanger) GSV General Systems Vehicle GSV Gross Standard Volume ) treatments, endovenous laser ablation (ELA Noun 1. ELA - an extreme leftist terrorist group formed in Greece in 1971 to oppose the military junta that ruled Greece from 1967 to 1974; a revolutionary group opposed to capitalism and imperialism and the United States Revolutionary People's Struggle ), endovenous radio frequency ablation (ERFA ERFA European Rail Freight Association ERFA Exclusive-Rights Free Agent ERFA Emeritus and Retired Faculty Association ERFA Endoluminal Radiofrequency Ablation ERFA Economic Research and Financial Analysis ERFA European Radio Frequency Agency ), and surgical stripping, as well as non- GSV treatments phlebectomy and sclerotherapy sclerotherapy /scle·ro·ther·a·py/ (skler?o-ther´ah-pe) injection of a chemical irritant into a vein to produce inflammation and eventual fibrosis and obliteration of the lumen, as for treatment of hemorrhoids. . Content Outline: Executive Summary Methodology 1.0 US Varicose Vein Treatment Market 2.0 Varicose Vein Surgery 3.0 Endovenous Radio Frequency Ablation 4.0 Endovenous Laser Ablation 5.0 Phlebectomy 6.0 Sclerotherapy Acronyms and Initialisms This list contains acronyms, initialisms, and pseudo-blends. For the purposes of this list:
List of Exhibits Executive Summary Chapter 1: US Varicose Vein Treatment Market Chapter 2: Varicose Vein Surgery Chapter 3: Endovenous Radiofrequency Ablation Chapter 4: Endovenous Laser Ablation Chapter 5: Phlebectomy Chapter 6: Sclerotherapy For more information visit http://www.researchandmarkets.com/reports/c44590 Source: Millennium Research Group |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion